$药明生物(02269)$
Wu Biologics launches $200m debut borrowing
Chinese pharmaceuticals company Wu Biologics has launched a debut offshore loan of $200m through sole lead Standard Chartered.
By Pan Yue27 Mar 2019
The new borrowing has a door-to-door life of three years and an average life of 2.8 years, according to a banker who received the invitation. The margin was priced at 220bp over Libor.